Alkermes plc. (27)
Browse by Contract Category
Contracts
-
Fourth Amendment to License and Collaboration Agreement between Alkermes Pharma Ireland Limited and Biogen Swiss Manufacturing GmbH, effective as of August 25, 2022
(Filed With SEC on November 2, 2022)
-
Form of Non-Employee Director New Director Grant Restricted Stock Unit (Time-Vesting) Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended
(Filed With SEC on July 27, 2022)
-
Description of Securities
(Filed With SEC on February 16, 2022)
-
Third Amendment to Purchase and Sale Agreement, dated August 17, 2020, by and among Alkermes Pharma Ireland Limited, Daravita Limited, Alkermes US Holdings, Inc. (as successor in...
(Filed With SEC on October 29, 2020)
-
Sixth Amendment to Lease between Alkermes, Inc. and GI TC 850 Winter Street, LLC, dated as of July 24, 2020
(Filed With SEC on October 29, 2020)
-
Agreement and Plan of Merger, dated as of November 14, 2019, by and among Alkermes plc, Alkermes, Inc., Thinker Merger Sub, Inc., Rodin Therapeutics, Inc., and Shareholder...
(Filed With SEC on November 25, 2019)
-
Form of Non-Employee Director New Director Grant Non-Qualified Stock Option Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended
(Filed With SEC on July 27, 2022)
-
Alkermes plc 2018 Stock Option and Incentive Plan, as amended
(Filed With SEC on July 7, 2022)
-
ALKERMESplc 2018 Stock Option and Incentive Plan, as amended
(Filed With SEC on February 16, 2022)
-
Summary of agreement reached on April 29, 2021 between Alkermes plc and Sarissa Capital Offshore Master Fund LP
(Filed With SEC on July 28, 2021)
-
Alkermes plc 2018 Stock Option and Incentive Plan, as amended
(Filed With SEC on June 14, 2021)
-
Description of Securities
(Filed With SEC on February 11, 2021)
-
Cooperation Agreement, dated December 10, 2020, by and among Alkermes plc, Elliott Investment Management L.P., Elliott Associates, L.P., Elliott Advisors (UK) Limited and Elliott...
(Filed With SEC on December 10, 2020)
-
Form of Restricted Stock Unit Award Certificate (Performance-Vesting) under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended
(Filed With SEC on July 29, 2020)
-
Form of Restricted Stock Unit (Time-Vesting) (Non-Employee Director) Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended
(Filed With SEC on July 29, 2020)
-
Form of Non-Qualified Stock Option (Non-Employee Director) Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended
(Filed With SEC on July 29, 2020)
-
Offer Letter between Alkermes, Inc. and Christian Todd Nichols, dated March 29, 2019
(Filed With SEC on July 29, 2020)
-
Alkermes plc 2018 Stock Option and Incentive Plan, as amended
(Filed With SEC on May 20, 2020)
-
Form of Indemnification Agreement entered into by and between Alkermes, Inc. and the executive officers and directors of Alkermes plc
(Filed With SEC on April 29, 2020)
-
Form of Deed of Indemnification entered into by and between Alkermes plc and the directors and Secretary of Alkermes plc
(Filed With SEC on April 29, 2020)
-
In accordance with Item 601(b)(2)(ii) of Regulation S-K, certain information (indicated by [**]) has been excluded from this exhibit because it is both not material and would...
(Filed With SEC on February 13, 2020)
-
Description of Securities
(Filed With SEC on February 13, 2020)
-
Second Amendment to Lease, dated May 10, 2019, by and between Alkermes, Inc. and PDM 900 Unit, LLC
(Filed With SEC on July 25, 2019)
-
Alkermes plc 2018 Stock Option and Incentive Plan, as amended
(Filed With SEC on May 22, 2019)
-
Second Amendment, effective as of January 31, 2019, to License and Collaboration Agreement by and between Alkermes Pharma Ireland Limited and Biogen Swiss Manufacturing GmbH dated...
(Filed With SEC on April 25, 2019)
-
Fifth Amendment to Lease between Alkermes, Inc. and GI TC 850 Winter Street, LLC, dated as of October 31, 2018
(Filed With SEC on February 15, 2019)
-
Second Amendment to Purchase and Sale Agreement, dated December 20, 2018, by and among Alkermes Pharma Ireland Limited, Daravita Limited, Alkermes US Holdings, Inc. (as successor...
(Filed With SEC on February 15, 2019)